NEW YORK (Reuters) - Johnson & Johnson reported disappointing quarterly revenue due to plunging U.S. sales of consumer products that continue to be recalled for quality-control lapses, and the diversified healthcare company forecast 2011 earnings below Wall Street expectations.
